Back to Journals » Clinical Epidemiology » Volume 4 » Issue 1
Quality of life and baseline characteristics associated with depressive symptoms among patients with heart disease
Authors Rejai, Giardino N, Krishnan S, Ockene, Rubenfire M , Jackson EA
Received 16 December 2011
Accepted for publication 11 January 2012
Published 24 July 2012 Volume 2012:4(1) Pages 181—186
DOI https://doi.org/10.2147/CLEP.S29247
Review by Single anonymous peer review
Peer reviewer comments 2
Sepehr Rejai,1 Nicholas D Giardino,2 Sangeetha Krishnan,1,3 Ira S Ockene,4 Melvyn Rubenfire,3 Elizabeth A Jackson1,3
1Michigan Cardiovascular Research and Reporting Program, 2Department of Psychiatry, 3Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA; 4Division of Cardiovascular Medicine, Department of Internal Medicine, University of Massachusetts Medical Center, Worcester, MA, USA
Abstract: We sought to examine factors associated with depressive symptoms among patients with heart disease. Data from 197 patients admitted for coronary artery disease were examined using multivariate predictive models. Women and unmarried patients were more likely to report depressive symptoms. In multivariate models, we observed that depressive symptoms were associated with the level of tangible social (but not emotional) support, bodily pain, and vitality, but not the number of comorbidities, gender, or marital status.
Keywords: heart disease, quality of life, depression
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.